Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines

In the United States, many blood collection organizations initiated programs to test all blood donors for antibodies to SARS-CoV-2, as a measure to increase donations and to assist in the identification of potential donors of COVID-19 convalescent plasma (CCP). As a result, it was possible to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodd, Roger Y, Spencer, Bryan R, Xu, Meng, Foster, Gregory A, Saá, Paula, Brodsky, Jaye P, Stramer, Susan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321690/
https://www.ncbi.nlm.nih.gov/pubmed/34373145
http://dx.doi.org/10.1016/j.tmrv.2021.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321690/
https://www.ncbi.nlm.nih.gov/pubmed/34373145
http://dx.doi.org/10.1016/j.tmrv.2021.07.001

Ejemplares similares